293 related articles for article (PubMed ID: 19409931)
1. Induction of multiple pro-inflammatory cytokines by respiratory viruses and reversal by standardized Echinacea, a potent antiviral herbal extract.
Sharma M; Anderson SA; Schoop R; Hudson JB
Antiviral Res; 2009 Aug; 83(2):165-70. PubMed ID: 19409931
[TBL] [Abstract][Full Text] [Related]
2. Bactericidal and anti-inflammatory properties of a standardized Echinacea extract (Echinaforce): dual actions against respiratory bacteria.
Sharma SM; Anderson M; Schoop SR; Hudson JB
Phytomedicine; 2010 Jul; 17(8-9):563-8. PubMed ID: 20036523
[TBL] [Abstract][Full Text] [Related]
3. Echinacea extracts modulate the pattern of chemokine and cytokine secretion in rhinovirus-infected and uninfected epithelial cells.
Sharma M; Arnason JT; Burt A; Hudson JB
Phytother Res; 2006 Feb; 20(2):147-52. PubMed ID: 16444669
[TBL] [Abstract][Full Text] [Related]
4. Echinacea extracts modulate the production of multiple transcription factors in uninfected cells and rhinovirus-infected cells.
Sharma M; Arnason JT; Hudson JB
Phytother Res; 2006 Dec; 20(12):1074-9. PubMed ID: 17009208
[TBL] [Abstract][Full Text] [Related]
5. Echinacea as an antiinflammatory agent: the influence of physiologically relevant parameters.
Sharma M; Schoop R; Hudson JB
Phytother Res; 2009 Jun; 23(6):863-7. PubMed ID: 19107735
[TBL] [Abstract][Full Text] [Related]
6. Changes in immunomodulatory properties of Echinacea spp. root infusions and tinctures stored at 4 degrees C for four days.
Senchina DS; McCann DA; Asp JM; Johnson JA; Cunnick JE; Kaiser MS; Kohut ML
Clin Chim Acta; 2005 May; 355(1-2):67-82. PubMed ID: 15820480
[TBL] [Abstract][Full Text] [Related]
7. The potential use of Echinacea in acne: control of Propionibacterium acnes growth and inflammation.
Sharma M; Schoop R; Suter A; Hudson JB
Phytother Res; 2011 Apr; 25(4):517-21. PubMed ID: 20830697
[TBL] [Abstract][Full Text] [Related]
8. Cytokine production by non-adherent mouse splenocyte cultures to Echinacea extracts.
Hwang SA; Dasgupta A; Actor JK
Clin Chim Acta; 2004 May; 343(1-2):161-6. PubMed ID: 15115689
[TBL] [Abstract][Full Text] [Related]
9. Antiviral activity of characterized extracts from echinacea spp. (Heliantheae: Asteraceae) against herpes simplex virus (HSV-I).
Binns SE; Hudson J; Merali S; Arnason JT
Planta Med; 2002 Sep; 68(9):780-3. PubMed ID: 12357386
[TBL] [Abstract][Full Text] [Related]
10. Prevention of influenza virus induced bacterial superinfection by standardized Echinacea purpurea, via regulation of surface receptor expression in human bronchial epithelial cells.
Vimalanathan S; Schoop R; Suter A; Hudson J
Virus Res; 2017 Apr; 233():51-59. PubMed ID: 28279802
[TBL] [Abstract][Full Text] [Related]
11. Echinacea and its alkylamides: effects on the influenza A-induced secretion of cytokines, chemokines, and PGE₂ from RAW 264.7 macrophage-like cells.
Cech NB; Kandhi V; Davis JM; Hamilton A; Eads D; Laster SM
Int Immunopharmacol; 2010 Oct; 10(10):1268-78. PubMed ID: 20674883
[TBL] [Abstract][Full Text] [Related]
12. Effects of Echinacea extracts on macrophage antiviral activities.
Senchina DS; Martin AE; Buss JE; Kohut ML
Phytother Res; 2010 Jun; 24(6):810-6. PubMed ID: 20041425
[TBL] [Abstract][Full Text] [Related]
13. Anticancer and antiviral activities of Youngia japonica (L.) DC (Asteraceae, Compositae).
Ooi LS; Wang H; Luk CW; Ooi VE
J Ethnopharmacol; 2004 Sep; 94(1):117-22. PubMed ID: 15261971
[TBL] [Abstract][Full Text] [Related]
14. Year-and-a-half old, dried Echinacea roots retain cytokine-modulating capabilities in an in vitro human older adult model of influenza vaccination.
Senchina DS; Wu L; Flinn GN; Konopka del N; McCoy JA; Widrlechner MP; Wurtele ES; Kohut ML
Planta Med; 2006 Oct; 72(13):1207-15. PubMed ID: 17021999
[TBL] [Abstract][Full Text] [Related]
15. Cytochrome P450 inhibitory action of Echinacea preparations differs widely and co-varies with alkylamide content.
Modarai M; Gertsch J; Suter A; Heinrich M; Kortenkamp A
J Pharm Pharmacol; 2007 Apr; 59(4):567-73. PubMed ID: 17430641
[TBL] [Abstract][Full Text] [Related]
16. Echinacea species (Echinacea angustifolia (DC.) Hell., Echinacea pallida (Nutt.) Nutt.,Echinacea purpurea (L.) Moench): a review of their chemistry, pharmacology and clinical properties.
Barnes J; Anderson LA; Gibbons S; Phillipson JD
J Pharm Pharmacol; 2005 Aug; 57(8):929-54. PubMed ID: 16102249
[TBL] [Abstract][Full Text] [Related]
17. Effects of Echinaforce® treatment on ex vivo-stimulated blood cells.
Ritchie MR; Gertsch J; Klein P; Schoop R
Phytomedicine; 2011 Jul; 18(10):826-31. PubMed ID: 21726792
[TBL] [Abstract][Full Text] [Related]
18. Applications of the phytomedicine Echinacea purpurea (Purple Coneflower) in infectious diseases.
Hudson JB
J Biomed Biotechnol; 2012; 2012():769896. PubMed ID: 22131823
[TBL] [Abstract][Full Text] [Related]
19. Effect of Echinacea augustifolia extract on cell viability and differentiation in mammary epithelial cells.
Starvaggi Cucuzza L; Motta M; Accornero P; Baratta M
Phytomedicine; 2008 Aug; 15(8):555-62. PubMed ID: 18424103
[TBL] [Abstract][Full Text] [Related]
20. Anti-viral properties and mode of action of standardized Echinacea purpurea extract against highly pathogenic avian influenza virus (H5N1, H7N7) and swine-origin H1N1 (S-OIV).
Pleschka S; Stein M; Schoop R; Hudson JB
Virol J; 2009 Nov; 6():197. PubMed ID: 19912623
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
